Cypress Capital Management LLC (Wy) Abbott Laboratories Transaction History
Cypress Capital Management LLC (Wy)
- $93.7 Million
- Q2 2024
A detailed history of Cypress Capital Management LLC (Wy) transactions in Abbott Laboratories stock. As of the latest transaction made, Cypress Capital Management LLC (Wy) holds 2,584 shares of ABT stock, worth $290,441. This represents 0.29% of its overall portfolio holdings.
Number of Shares
2,584
Previous 2,784
7.18%
Holding current value
$290,441
Previous $316,000
15.19%
% of portfolio
0.29%
Previous 0.34%
Shares
16 transactions
Others Institutions Holding ABT
# of Institutions
3,135Shares Held
1.33BCall Options Held
8.63MPut Options Held
7.17M-
Vanguard Group Inc Valley Forge, PA166MShares$18.7 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$14.7 Billion0.31% of portfolio
-
State Street Corp Boston, MA74.4MShares$8.36 Billion0.34% of portfolio
-
Capital International Investors Los Angeles, CA71.8MShares$8.07 Billion1.57% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.2MShares$6.43 Billion1.34% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $197B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...